NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $758,000 | -50.1% | 42,307 | -3.4% | 0.00% | -50.0% |
Q2 2019 | $1,520,000 | -6.8% | 43,807 | -12.2% | 0.01% | -11.1% |
Q1 2019 | $1,631,000 | -5.0% | 49,893 | -2.2% | 0.01% | -18.2% |
Q4 2018 | $1,716,000 | -63.2% | 51,022 | -33.3% | 0.01% | -56.0% |
Q3 2018 | $4,659,000 | +164.3% | 76,482 | +111.8% | 0.02% | +150.0% |
Q2 2018 | $1,763,000 | – | 36,115 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |